Who
J. E. Davis
CEO and President
Company insider
Files Form 4 as: CEO and President, Quest Diagnostics.
In numbers
- Trades disclosed
- 142
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $58.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 May 2014
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $2.4M10,000 at $242.72 | filing |
| 1 Sep 2026filed 3 Sep 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $2.4M10,000 at $242.72 | filing |
| 1 Jun 2026filed 2 Jun 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $1.9M10,000 at $194.14 | filing |
| 1 Jun 2026filed 2 Jun 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $1.9M10,000 at $194.14 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $10.6M51,652 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $5.4M26,414 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $10.6M51,652 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $5.4M26,414 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $608K2,968 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $2.1M10,000 at $212.52 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $608K2,968 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $2.1M10,000 at $212.52 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —15,857 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $503K2,396 at $210.01 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $784K3,788 at $206.99 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —73,225 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —73,225 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —15,857 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $503K2,396 at $210.01 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $784K3,788 at $206.99 | filing |
News
Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.13 EPSDGX · themarketsdaily.com · 22 Oct 2026Quest Diagnostics (NYSE: DGX) lifts guidance after revenue jumps 10%DGX · dailypolitical.com · 22 Oct 2026Quest Diagnostics Incorporated $DGX Stock Sold by Willis Investment CounselDGX · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name J. E. Davis; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.